Sensorion Archives

Home Sensorion

Latest Posts

News and Trends 6 Jul 2023

Positive data from Sensorion hearing loss study

Sensorion, which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, has reported further analysis from its Proof of Concept…

July 6, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 9 May 2023

The future of cell and gene therapy in hearing loss

By Nawal Ouzren, CEO of Sensorion Therapeutics for inner ear hearing loss remains an unconquered frontier and the unmet need is vast. Hearing loss is predicted to affect nearly 2.5…

May 9, 2023 - 3 minutesmins - By External Contributor

Best in Biotech 21 May 2019

The Top 20 Women in Leading Biotech Roles in Europe

The biotech industry has often been criticized for its lack of gender diversity. While there is still a long way to go to achieve ideal levels of equality, there are…

May 21, 2019 - 12 minutesmins - By Jonathan Smith

Best in Biotech 29 Mar 2023

5 hearing loss biotech companies you should know about

More than 1.5 billion people - nearly 20% of the world’s population - live with hearing loss globally, with 430 million suffering from disabling hearing loss. In this article, we…

March 29, 2023 - 7 minutesmins - By Willow Shah-Neville

More News! 18 Dec 2017

French Biotech will work with the World’s Leader in Hearing Implants

Sensorion and Cochlear will explore if a combination of a drug and a hearing implant can improve the treatment of hearing loss. Based in the French city of Montpellier, Sensorion…

December 18, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 31 Jan 2023

Sensorion and EVEON collaborating on injection system to deliver gene therapy inner ear treatments

Sensorion and EVEON are collaborating on the design and development of an injection system for the delivery of Sensorion’s gen therapy products to the inner ear. Therapies for treating genetic…

January 31, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 3 Jan 2023

Sensorion announces first patient enrolled in cisplatin-induced ototoxicity trial

Sensorion has announced that the first patient has been enrolled in its phase 2a proof of concept clinical trial of SENS-401 (Arazasetron) in patients suffering from cisplatin-induced ototoxicity. Cisplatin and…

January 3, 2023 - 3 minutesmins - By Jim Cornall

More News! 30 Nov 2022

FDA grants Sensorion Orphan Drug Designation for hearing loss drug

Sensorion a clinical-stage biotechnology company has announced that the US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to OTOF-GT, its lead gene therapy program. The drug…

November 30, 2022 - 3 minutesmins - By Liza Laws

More News! 7 Nov 2022

Sensorion granted rare pediatric disease designation by FDA for lead therapy gene

Sensorion has announced that the US Food and Drug Administration (FDA) has granted rare pediatric disease designation to its lead therapy gene candidate, OTOF-GT. The gene therapy is intended for…

November 7, 2022 - 2 minutesmins - By Liza Laws

More News! 24 Oct 2022

Sensorion gets go-ahead from France for trial of drug to prevent hearing loss

Biotech company, Sensorion, today (October 24) announced that the initiation of a proof of concept (PoC) clinical trial of SENS-401 (Arazasetron) in patients with Cisplatin-Induced Ototoxicity (CIO) has been approved…

October 24, 2022 - 3 minutesmins - By Liza Laws

News and Trends 12 Sep 2022

Sensorion receives positive opinion from EMA for treatment of hearing loss

The European Medicines Agency (EMA) through its Committee for Orphan Medicinal Products (COMP) has adopted a positive opinion for a treatment for otoferlin gene mediated hearing loss. Clinical-stage biotech, Sensorion,…

September 12, 2022 - 3 minutesmins - By Liza Laws

News and Trends 1 Jul 2022

Progress for hearing preservation trial after Australian approval granted

Approval has been granted by the Australian authorities to allow a French company to progress with a clinical trial testing cochlear implants. Montpellier-based Sensorion will start its proof of concept…

July 1, 2022 - 3 minutesmins - By Liza Laws

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Power your event with partnering to deliver attendee ROI. Learn more!

View all companies A-Z

Partner with world-leading academics working on sustainable materials R&D

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inpart, the leading platform for biopharma partnering